BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 23977452)

  • 1. Liver Injury and the Activation of the Hepatic Myofibroblasts.
    Jiang JX; Török NJ
    Curr Pathobiol Rep; 2013 Sep; 1(3):215-223. PubMed ID: 23977452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts.
    Liang S; Kisseleva T; Brenner DA
    Front Physiol; 2016; 7():17. PubMed ID: 26869935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERK Pathway in Activated, Myofibroblast-Like, Hepatic Stellate Cells: A Critical Signaling Crossroad Sustaining Liver Fibrosis.
    Foglia B; Cannito S; Bocca C; Parola M; Novo E
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31159366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis.
    Iwaisako K; Brenner DA; Kisseleva T
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):65-8. PubMed ID: 22320919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of NADPH oxidases in the redox biology of liver fibrosis.
    Crosas-Molist E; Fabregat I
    Redox Biol; 2015 Dec; 6():106-111. PubMed ID: 26204504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated TGF-β signaling.
    Borkham-Kamphorst E; Schaffrath C; Van de Leur E; Haas U; Tihaa L; Meurer SK; Nevzorova YA; Liedtke C; Weiskirchen R
    Biochim Biophys Acta; 2014 May; 1843(5):902-14. PubMed ID: 24487063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis.
    Mallat A; Lotersztajn S
    Am J Physiol Cell Physiol; 2013 Oct; 305(8):C789-99. PubMed ID: 23903700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies.
    Xu J; Liu X; Koyama Y; Wang P; Lan T; Kim IG; Kim IH; Ma HY; Kisseleva T
    Front Pharmacol; 2014; 5():167. PubMed ID: 25100997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin extra domain-A promotes hepatic stellate cell motility but not differentiation into myofibroblasts.
    Olsen AL; Sackey BK; Marcinkiewicz C; Boettiger D; Wells RG
    Gastroenterology; 2012 Apr; 142(4):928-937.e3. PubMed ID: 22202457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNFα in liver fibrosis.
    Yang YM; Seki E
    Curr Pathobiol Rep; 2015 Dec; 3(4):253-261. PubMed ID: 26726307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human liver myofibroblasts during development and diseases with a focus on portal (myo)fibroblasts.
    Lepreux S; Desmoulière A
    Front Physiol; 2015; 6():173. PubMed ID: 26157391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoglobin as a Marker of Hepatic Stellate Cell-derived Myofibroblasts.
    Kawada N
    Front Physiol; 2015; 6():329. PubMed ID: 26617531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of Hepatic Stellate Cells to TGFB1 Differs from the Response of Myofibroblasts. Decorin Protects against the Action of Growth Factor.
    Fullár A; Firneisz G; Regős E; Dudás J; Szarvas T; Baghy K; Ramadori G; Kovalszky I
    Pathol Oncol Res; 2017 Apr; 23(2):287-294. PubMed ID: 27495255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis.
    Kim WH; Matsumoto K; Bessho K; Nakamura T
    Am J Pathol; 2005 Apr; 166(4):1017-28. PubMed ID: 15793283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin suppresses activation of hepatic stellate cells through RORα-mediated inhibition of 5-lipoxygenase.
    Shajari S; Laliena A; Heegsma J; Tuñón MJ; Moshage H; Faber KN
    J Pineal Res; 2015 Oct; 59(3):391-401. PubMed ID: 26308880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.
    Mormone E; George J; Nieto N
    Chem Biol Interact; 2011 Sep; 193(3):225-31. PubMed ID: 21803030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Myofibroblasts of Different Origins to Liver Fibrosis.
    Fausther M; Lavoie EG; Dranoff JA
    Curr Pathobiol Rep; 2013 Sep; 1(3):225-230. PubMed ID: 23997993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis.
    Oakley F; Meso M; Iredale JP; Green K; Marek CJ; Zhou X; May MJ; Millward-Sadler H; Wright MC; Mann DA
    Gastroenterology; 2005 Jan; 128(1):108-20. PubMed ID: 15633128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Origins and functions of liver myofibroblasts.
    Lemoinne S; Cadoret A; El Mourabit H; Thabut D; Housset C
    Biochim Biophys Acta; 2013 Jul; 1832(7):948-54. PubMed ID: 23470555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.